Cell Therapy Training Course Sponsorships

THE ISCT- ASTCT CLINICAL CELL THERAPY LEADERSHIP TRAINING PROGRAM IS MADE POSSIBLE WITH THE HELP OF OUR GENEROUS SPONSORS!

Thank you to our 2023 sponsors who have helped to make it possible to provide 15 full-tuition scholarships to the next generation of clinical translational cell and gene therapy professionals and bridge the workforce development gap facing the sector.

Why Support the Clinical Cell Therapy Leadership Training Program?

Showcase your organization as a solution provider in the CGT product development pipeline.
Network and create lasting relationships with current and future leaders in CGT.
Increase visibility and maximize brand awareness with a relevant and targeted audience.
Demonstrate Corporate Social Responsibility by participating in a critical program that addresses the workforce development crisis.

GOLD SPONSORS

What drew OmniaBio to support the ISCT – ASTCT Cell Therapy Training Course?

CCRM and OmniaBio recognize the need to engage in cross-industry discourse on the different activities and collaborations required to advance a therapy from lab to market. Students trained in undergraduate programs are equipped with mostly theoretical knowledge, while graduate programs offer highly specialized training on just a few components of a given discovery. The CTTC weaves together all the components that are vital to the translation and development of CGTs that often get overlooked in university programs.

Highlighting these essential components, the CTTC offers insights into a wide range of topics to equip researchers and academics with a deeper knowledge of the “bigger picture” of the industry. CCRM and OmniaBio wanted to support this program because it is focused on providing training to academics and researchers who are still in the early stages of their careers, thereby creating exciting opportunities for knowledge dissemination, starting where participants are, and moving them forward. These early scholars will bring this knowledge into their own classrooms, labs and teachings to effectively train the next generation of CGT leaders.

This five-day course complements the offerings of CATTI and other training providers who are bridging the gaps in skill and knowledge, and moving beyond just theory-based learning. It is essential that the industry provides these kinds of comprehensive training systems, which cover the full spectrum of CGT work, from pre-clinical research to cell manufacturing, and clinical trials to regulatory components.

What drew CSafe to support the ISCT – ASTCT Cell Therapy Training Course?

As a relatively nascent but fast-growing sector, cell and gene therapy requires expert professional organizations to guide standards development, education, and workforce training. Together, as sector leaders, ISCT and ASTCT are uniquely positioned to provide training to leaders in science and medicine interested in expanding into CGT.

By sponsoring a training course provided by ISCT and ASTCT – established leaders in the field of cell and gene therapy – CSafe can contribute to the further development of expertise within the medical and scientific community, ultimately leading to broader application of these therapies and greater patient access.

As the CGT sector gathers again in person after the COVID-19 pandemic, it is especially important to support these types of in-person events where thought leaders and rising leaders of the industry can come together to share, learn, and collaborate.